Reviews and commentary informed by clinical practice and evidence.
Evaluating the role of language models as adjunctive tools in primary care and metabolic screening.
A structured review of pharmacological interventions targeting mTOR pathways in the context of healthy aging.
Which markers to trust, which interventions have signal, and what remains uncertain.
A measured look at continuous glucose monitoring outside its established indications.
Biological age testing is popular; interpretation lags behind adoption.
Newer molecules, broader indications, and open questions in long-term use.
